Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

AGYS, COUV, AMRN, CRWE, ALTH - Stocks to Watch Report!



Agilysys Inc. (Nasdaq:AGYS) a leading provider of innovative information technology and hospitality software solutions, announced that they received the prestigious Platinum G&L Technology Impact Award for its LMS+ property management solution. The award, given by Gaming & Leisure magazine, recognizes companies that offer products that increase revenue or decrease costs.

"It was our sincere pleasure to honor Agilysys with the first place Platinum G&L Technology Impact Award," said Jeannie Caruso, publisher of Gaming & Leisure magazine and host of the G&L Roundtable. "The company continues to expand its product line, development strategy and global market reach in the forward direction that is aligned with the industry's expectations and needs.

Agilysys, Inc., together with its subsidiaries, provides information technology (NYSE:IT) solutions to corporate and public-sector customers primarily in North America.


Corporate Universe Inc. (Pink Sheets:COUV) is pleased to announce the following corporate and operational matters to its shareholders and followers.

  • COUV is opening its new corporate office at 3771 Nesconset Highway, South Setauket, NY, effective October 4, 2010. The new office will allow the Company to operate all of its divisions and subsidiaries in a centrally located place. Manhattan Transfer Registrar Company will continue to be located in Miller Place.
  • Now that the corporate changes are fully implemented, including the name change to Corporate Universe Inc., trading under the symbol (Pink Sheets:COUV), and the forward split of 10 new shares for each old share of common stock, the company is ready for business and intends to keep its followers advised on a timely basis.
  • COUV corporate website,, went live just recently, and has officially been launched!
    The management will continue to update and improve it over the coming weeks.

The Company has formally retained Mina Mar Marketing Group Inc. as its Investor relations (NYSE:IR) firm.

John Ahearn, President, stated, "In a few short weeks we have made great strides in getting our company reorganized and moving forward.

I believe that many great things are in store for Corporate Universe Inc. in the future and all of us are working very hard and diligently to make it happen.

As part of our growth strategy COUV intends to grow the company both organically and through mergers of successful companies in our business industry or business space.

COUV management and the Mina Mar Group Mergers and Acquisition Division will be meeting to discuss potential business opportunities and candidates in the near future."

More updates will be provided shortly!!


Amarin Corporation plc (Nasdaq:AMRN) announced that A recent survey from PricewaterhouseCoopers found that life sciences firms believe that industry-FDA relationships have bettered since Obama took office. In fact, 80% of those surveyed said in the last two years the FDA has provided better guidance about its expectations. Better guidance leads to fewer letdowns for drug manufacturers, and less risk for speculative investors.

The Bedford Report examines the outlook for companies in the Drug Manufacturers - Others Industry and provides research reports on Orexigen Therapeutics, Inc. (NASDAQ:OREX) and Amarin Corporation PLC (NASDAQ:AMRN). Access to the full company reports can be found at:

Amarin Corporation plc operates as a biopharmaceutical company with a focus on cardiovascular diseases. Its cardiovascular programs focus in the field of lipid science and the known therapeutic benefits of essential fatty acids in cardiovascular disease.



Orofino Gold Corp. (ORFG.PK) is a US (Nevada) company established for the purpose of creating a significant exploration and mining group to operate in Colombia.

Orofino has major criteria by which they select properties that includes:

* Significant historical production
* Favorable geology for hosting major ore bodies
* Significant property area for large target exploration
* Recent results available
* Favorable infrastructure and access to allow mine development
* Receptive local government and populace.

Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of existing projects and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

Orofino is a gold development Company with existing production and options on several other producers.


Allos Therapeutics, Inc. (Nasdaq:ALTH) announced the presentation of further data from the Company’s randomized, international Phase 2b investigational study of FOLOTYN® (pralatrexate injection) relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.

The presentation, which includes additional results from several pre-specified analyses, reinforces the favorable survival data observed with FOLOTYN in patients with advanced NSCLC—including outcomes observed in patients with non-squamous and squamous histologies, as well as results from an analysis adjusting for important baseline factors and potential imbalances in the number of patients between cohorts.

Allos Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing anti-cancer therapeutics. It is developing FOLOTYN (pralatrexate injection), a folate analogue metabolic inhibitor.


Sign-Up For Free Stock Alerts At

business Card 3


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Corporate Universe Inc., COUV.PK

Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.